Consider taking part in a clinical trial that is currently enrolling to treat for early stage Alzheimer's disease.
To qualify, participants must:
If you or someone you know are concerned about memory loss or alzheimer's disease, you may be eligible for a clinical research study called ENGAGE The ENGAGE study will assess the safety and potential efficacy of an investigational medication to determine whether it can slow the progression of symptoms in early Alzheimer's disease, such as memory loss.
In order to qualify you must:
What if we could slow your or your loved one's Alzheimer's with sleep? ReCOGNITION is a research study testing whether an investigational medication, which has sleep promoting effects, can help to slow cognitive deterioration, or improve cognitive function.
CHAMP-HF is an observatioanl study. It does not require any additional office visits or medicine outside of normal care. The study will look at the treatment of heart failure and reasons for chnages in treatment.
To qualify for CHAMP-HF, participants must: